Skip to main content

Disease-Modifying Anti-Rheumatic Drug Therapy for Rheumatoid Arthritis (ART)

CBE ID
0054
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

The percentage of patients 18 years of age and older who were diagnosed with rheumatoid arthritis and who were dispensed at least one ambulatory prescription for a disease-modifying anti-rheumatic drug (DMARD).

        • 1.14 Numerator

          Patients who were dispensed at least one ambulatory prescription for a disease-modifying anti-rheumatic drug (DMARD) during the measurement year.

        • 1.15 Denominator

          All patients, ages 18 years and older by December 31 of the measurement year, who had two of the following with different dates of service on or between January 1 and November 30 of the measurement year:

          - Outpatient visit, with any diagnosis of rheumatoid arthritis
          - Nonacute inpatient discharge, with any diagnosis of rheumatoid arthritis

          Visit type need not be the same for the two visits.

        • Exclusions

          Exclude patients who use hospice services or elect to use a hospice benefit any time during the measurement year, regardless of when the services began.

          Exclude patients who have a diagnosis of HIV. Look for evidence of HIV diagnosis as far back as possible in the patient’s history through the end of the measurement year.

          Exclude patients who have a diagnosis of pregnancy any time during the measurement year.

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Primary Care and Chronic Illness Fall Cycle 2019
          Initial Endorsement
          Last Updated
          Removal Date